Form 8-K - Current report:
SEC Accession No. 0001193125-18-331312
Filing Date
2018-11-20
Accepted
2018-11-20 16:06:06
Documents
3
Period of Report
2018-11-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d674636d8k.htm 8-K 16466
2 EXHIBIT 99.1 d674636dex991.htm EX-99.1 13683
3 GRAPHIC g674636g1120001502138.jpg GRAPHIC 2512
  Complete submission text file 0001193125-18-331312.txt   34825
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 181195649
SIC: 2834 Pharmaceutical Preparations